ArticleFrontiers in immunology2022

Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.

Hongda Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.